Beneficial effects of coronary revascularization in patients with ischaemic left ventricular dysfunction with and without anginal symptoms

Alessia Gimelli, J. A M Neto, Claudio Marcassa, Paolo Ferrazzi, Mattia Glauber, Paolo Marzullo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Therapy for ischaemic congestive heart failure has been well documented in patients with angina. The goal of this study was to compare the benefit of revascularization in patients with and without chest pain. A series of 180 patients with ischaemic heart failure symptoms (New York Heart Association III-IV class) and low ejection fraction (28±9%) were recruited and followed for 3 years. Group A, 97/180 patients, had chest pain. Group B, 83/180 patients, did not have angina. The two groups did not differ with respect to known determinants of postinfarction prognosis. The relative presence of viable tissue versus scar was defined by Thallium-201 uptake. Intraoperative mortality was 5 and 7% in Groups A and B (P=not significant); in particular, in both groups, it was lower when only patients with mostly viable myocardium were considered. At 6 months, the presence of viable myocardium was highly predictive of improvement of heart failure symptoms and wall motion abnormalities. At 3 years, revascularized patients of Group A with mostly viable myocardium had a survival of 89% compared to 87% for corresponding Group B patients (P=not significant). In conclusion, similarly to patients with angina, patients with left ventricular dysfunction, maintained viability and without anginal symptoms may benefit from coronary revascularization.

Original languageEnglish
Pages (from-to)9-15
Number of pages7
JournalInteractive Cardiovascular and Thoracic Surgery
Volume1
Issue number1
DOIs
Publication statusPublished - Sep 2002

Fingerprint

Left Ventricular Dysfunction
Myocardium
Heart Failure
Chest Pain
Thallium
Cicatrix
Survival
Mortality

Keywords

  • Ischemic heart failure
  • Prognosis
  • Revascularization
  • Viability

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

Beneficial effects of coronary revascularization in patients with ischaemic left ventricular dysfunction with and without anginal symptoms. / Gimelli, Alessia; Neto, J. A M; Marcassa, Claudio; Ferrazzi, Paolo; Glauber, Mattia; Marzullo, Paolo.

In: Interactive Cardiovascular and Thoracic Surgery, Vol. 1, No. 1, 09.2002, p. 9-15.

Research output: Contribution to journalArticle

@article{cb01096d458b4a02b9d296c89035a651,
title = "Beneficial effects of coronary revascularization in patients with ischaemic left ventricular dysfunction with and without anginal symptoms",
abstract = "Therapy for ischaemic congestive heart failure has been well documented in patients with angina. The goal of this study was to compare the benefit of revascularization in patients with and without chest pain. A series of 180 patients with ischaemic heart failure symptoms (New York Heart Association III-IV class) and low ejection fraction (28±9{\%}) were recruited and followed for 3 years. Group A, 97/180 patients, had chest pain. Group B, 83/180 patients, did not have angina. The two groups did not differ with respect to known determinants of postinfarction prognosis. The relative presence of viable tissue versus scar was defined by Thallium-201 uptake. Intraoperative mortality was 5 and 7{\%} in Groups A and B (P=not significant); in particular, in both groups, it was lower when only patients with mostly viable myocardium were considered. At 6 months, the presence of viable myocardium was highly predictive of improvement of heart failure symptoms and wall motion abnormalities. At 3 years, revascularized patients of Group A with mostly viable myocardium had a survival of 89{\%} compared to 87{\%} for corresponding Group B patients (P=not significant). In conclusion, similarly to patients with angina, patients with left ventricular dysfunction, maintained viability and without anginal symptoms may benefit from coronary revascularization.",
keywords = "Ischemic heart failure, Prognosis, Revascularization, Viability",
author = "Alessia Gimelli and Neto, {J. A M} and Claudio Marcassa and Paolo Ferrazzi and Mattia Glauber and Paolo Marzullo",
year = "2002",
month = "9",
doi = "10.1016/S1569-9293(02)00002-6",
language = "English",
volume = "1",
pages = "9--15",
journal = "Interactive Cardiovascular and Thoracic Surgery",
issn = "1569-9293",
publisher = "European Association for Cardio-Thoracic Surgery",
number = "1",

}

TY - JOUR

T1 - Beneficial effects of coronary revascularization in patients with ischaemic left ventricular dysfunction with and without anginal symptoms

AU - Gimelli, Alessia

AU - Neto, J. A M

AU - Marcassa, Claudio

AU - Ferrazzi, Paolo

AU - Glauber, Mattia

AU - Marzullo, Paolo

PY - 2002/9

Y1 - 2002/9

N2 - Therapy for ischaemic congestive heart failure has been well documented in patients with angina. The goal of this study was to compare the benefit of revascularization in patients with and without chest pain. A series of 180 patients with ischaemic heart failure symptoms (New York Heart Association III-IV class) and low ejection fraction (28±9%) were recruited and followed for 3 years. Group A, 97/180 patients, had chest pain. Group B, 83/180 patients, did not have angina. The two groups did not differ with respect to known determinants of postinfarction prognosis. The relative presence of viable tissue versus scar was defined by Thallium-201 uptake. Intraoperative mortality was 5 and 7% in Groups A and B (P=not significant); in particular, in both groups, it was lower when only patients with mostly viable myocardium were considered. At 6 months, the presence of viable myocardium was highly predictive of improvement of heart failure symptoms and wall motion abnormalities. At 3 years, revascularized patients of Group A with mostly viable myocardium had a survival of 89% compared to 87% for corresponding Group B patients (P=not significant). In conclusion, similarly to patients with angina, patients with left ventricular dysfunction, maintained viability and without anginal symptoms may benefit from coronary revascularization.

AB - Therapy for ischaemic congestive heart failure has been well documented in patients with angina. The goal of this study was to compare the benefit of revascularization in patients with and without chest pain. A series of 180 patients with ischaemic heart failure symptoms (New York Heart Association III-IV class) and low ejection fraction (28±9%) were recruited and followed for 3 years. Group A, 97/180 patients, had chest pain. Group B, 83/180 patients, did not have angina. The two groups did not differ with respect to known determinants of postinfarction prognosis. The relative presence of viable tissue versus scar was defined by Thallium-201 uptake. Intraoperative mortality was 5 and 7% in Groups A and B (P=not significant); in particular, in both groups, it was lower when only patients with mostly viable myocardium were considered. At 6 months, the presence of viable myocardium was highly predictive of improvement of heart failure symptoms and wall motion abnormalities. At 3 years, revascularized patients of Group A with mostly viable myocardium had a survival of 89% compared to 87% for corresponding Group B patients (P=not significant). In conclusion, similarly to patients with angina, patients with left ventricular dysfunction, maintained viability and without anginal symptoms may benefit from coronary revascularization.

KW - Ischemic heart failure

KW - Prognosis

KW - Revascularization

KW - Viability

UR - http://www.scopus.com/inward/record.url?scp=0345258028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345258028&partnerID=8YFLogxK

U2 - 10.1016/S1569-9293(02)00002-6

DO - 10.1016/S1569-9293(02)00002-6

M3 - Article

VL - 1

SP - 9

EP - 15

JO - Interactive Cardiovascular and Thoracic Surgery

JF - Interactive Cardiovascular and Thoracic Surgery

SN - 1569-9293

IS - 1

ER -